PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
- PMID: 25915768
- DOI: 10.7326/M15-0920
PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
Comment on
-
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.Ann Intern Med. 2015 Jul 7;163(1):40-51. doi: 10.7326/M14-2957. Ann Intern Med. 2015. PMID: 25915661
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous